Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients
Bih-Rong Wei, Shelley B. Hoover, Mark M. Ross et al. · 2009
Read Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients by Bih-Rong Wei, Shelley B. Hoover, Mark M. Ross et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007670.txt.
Description
Bih-Rong Wei and colleagues published a study in PLOS ONE in 2009 on a blood marker for ovarian cancer spread. Epithelial ovarian cancer often spreads across the peritoneum, the abdominal lining. Gauging that tumor burden usually requires surgery or imaging. The team measured a protein called S100A6 in the blood of mice with the disease. They then checked the same marker against disease stage in patients.
In mice, serum S100A6 concentration predicted the peritoneal tumor burden. In patients, higher levels were associated with advanced stage. A blood test that tracks abdominal spread could help monitor treatment without repeated surgery. Ovarian cancer is usually caught late, so every monitoring tool counts. The study moves S100A6 from a laboratory observation toward a clinical candidate. It must still prove itself in larger patient groups.
Catalog record
| CREATOR | Bih-Rong Wei, Shelley B. Hoover, Mark M. Ross et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007670